Invitae logo TwitterFacebookLinkedInInvitae Blog

Order today: Full CHEK2 and new cancer genes

Invitae now offers full coverage of CHEK2 and several new cancer genes for the same low price, giving you even more choices when selecting the right genes and multi-gene panels.

You can also scroll down and register to download a flyer showing the new panels: At a glance: The Invitae advantage for BRCA and beyond.

  Start my order   |     Have an Invitae representative contact me

NEW PANEL:
 
Hereditary Gynecologic Cancers, High-Risk Panel
Includes nine genes (BRCA1, BRCA2, TP53, PTEN, PMS2*, MLH1, MSH2, MSH6, EPCAM), all with published management guidelines.

NEW GENES ADDED TO OUR TEST CATALOG:
 
 Full CHEK2
 BARD1
 MRE11A
 RAD50
 CTRC

UPDATED WITH FULL CHEK2:
 
Hereditary Pancreatic Cancer Panel
We also added CTRC to consider when ordering. As always with Invitae, you can add CTRC to any order for no additional charge.

UPDATED:
 
Hereditary Breast and Gynecologic Cancers Panel (Formerly Women’s Hereditary Cancer Panel)
 
Hereditary Breast Cancer, Extended Panel
 
Hereditary Breast Cancer, Moderate-Risk Panel
 

Hereditary Cancer Syndromes Panel

}
 
 
Added 3 of our new genes: BARD1, MRE11A, RAD50

 
Updated with full CHEK2
 
Added NF1** and FANCC
 
*PMS2: Exons 12-15 are not included in sequencing or deletion/duplication analysis.
**NF1: Exons 16-24 and 31-35 are not included in deletion/duplication analysis.
Register to download a flyer showing the new panels: At a glance: The Invitae advantage for BRCA and beyond.

Invitae advantage chart